You are here

Bioreactor for Enhanced T-cell Based Therapy of Melanoma

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43CA108381-01
Agency Tracking Number: CA108381
Amount: $124,154.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
AASTROM BIOSCIENCES, INC. BOX 376
ANN ARBOR, MI 48105
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 DOUGLAS Smith
 (734) 930-5789
 DSMITH@AASTROM.COM
Business Contact
 ALAN WRIGHT
Phone: (734) 930-5555
Email: AWRIGHT@AASTROM.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): Malignant melanoma is a significant and deadly form of cancer worldwide. Emerging evidence has shown that melanoma cells express tumor-associated antigens that are specifically recognized by the immune system. Melanom

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government